Heterogeneity of circulating tumor cells in primary breast cancer patients

被引:0
|
作者
Bystricky, Branislav
Karaba, Marian
Benca, Juraj
Vavrova, Ludmila
Markus, Jan
Konecny, Michal
Pindak, Daniel
Sufliarsky, Jozef
Mardiak, Jozef
Mego, Michal
机构
[1] Univ Hosp Trencin, Trencin, Slovakia
[2] Natl Canc Inst, Bratislava, Slovakia
[3] St Elisabeth Oncol Inst, Dept Genet, Bratislava, Slovakia
[4] Comenius Univ, Fac Med, Natl Canc Inst, Dept Oncol 2, Bratislava, Slovakia
[5] Comenius Univ, Fac Med, Oncol Clin 2, Bratislava, Slovakia
[6] Natl Canc Inst, Dept Clin Oncol, Bratislava, Slovakia
[7] Comenius Univ, Fac Med, Dept Oncol 2, Bratislava, Slovakia
[8] Natl Canc Inst, Bratislava, Slovakia
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e22037
引用
收藏
页数:1
相关论文
共 50 条
  • [31] A multiplexed immunofluorescence identifies phenotypic heterogeneity of circulating tumor cells in breast cancer
    Kamal, M.
    Zhang, R.
    Walker, M.
    Squires, R.
    Talbert, B.
    Dooley, W.
    Razaq, W.
    Tanaka, T.
    CANCER RESEARCH, 2017, 77
  • [32] Elucidating HER2 molecular heterogeneity of circulating tumor cells among breast cancer patients
    Leong, Man Chun
    Lim, Tse Hui
    Tan, Chye Ling
    Chua, Yong Wei
    Lim, Elaine Hsuen
    Loh, Kiley Wei Jen
    Lee, Guek Eng
    Dent, Rebecca
    Ng, Raymond Chee Hui
    Wu, Andrew
    Lim, Wan-Teck
    Lim, Alvin Soon-Tiong
    Yap, Yoon-Sim
    CANCER RESEARCH, 2016, 76
  • [33] The influence of removal of primary tumor on incidence and phenotype of circulating tumor cells in primary breast cancer
    Malgorzata Banys
    Natalia Krawczyk
    Sven Becker
    Jolanta Jakubowska
    Annette Staebler
    Diethelm Wallwiener
    Tanja Fehm
    Ralf Rothmund
    Breast Cancer Research and Treatment, 2012, 132 : 121 - 129
  • [34] Relationship Between Circulating Tumor Cells and Peripheral T-Cells in Patients with Primary Breast Cancer
    Gruber, Ines
    Landenberger, Nicole
    Staebler, Annette
    Hahn, Markus
    Wallwiener, Diethelm
    Fehm, Tanja
    ANTICANCER RESEARCH, 2013, 33 (05) : 2233 - 2238
  • [35] The influence of removal of primary tumor on incidence and phenotype of circulating tumor cells in primary breast cancer
    Banys, Malgorzata
    Krawczyk, Natalia
    Becker, Sven
    Jakubowska, Jolanta
    Staebler, Annette
    Wallwiener, Diethelm
    Fehm, Tanja
    Rothmund, Ralf
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (01) : 121 - 129
  • [36] Cancer gene panel analysis of cultured circulating tumor cells and primary tumor tissue from patients with breast cancer
    Hwang, Eunjoo
    Uh, Ji-Hyun
    Lee, Hye Seon
    Lee, Cham Han
    Lee, Soo Jeong
    Ahn, Sei Hyun
    Son, Byung Ho
    Lee, Jong Won
    Yu, Jong Han
    Kwon, Nak-Jung
    Lee, Woo Chung
    Yang, Kap-Seok
    Choi, Sung Ho
    Kim, Myoung Shin
    Lee, Jinseon
    Jeon, Byung Hee
    ONCOLOGY LETTERS, 2017, 13 (06) : 4627 - 4632
  • [37] Phenotypic characteristic of circulating tumor cells in primary nonmetastatic breast cancer
    Shlyakhtunou, Y.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S147 - S147
  • [38] Prognostic value of circulating tumor cells in primary and metastatic breast cancer
    Aurilio, Gaetano
    Sciandivasci, Angela
    Munzone, Elisabetta
    Sandri, Maria Teresa
    Zorzino, Laura
    Cassatella, Maria Cristina
    Verri, Elena
    Rocca, Maria Cossu
    Nole, Franco
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (02) : 203 - 214
  • [39] Circulating tumor cells and vitamin D in primary breast cancer.
    Mego, Michal
    Vlkova, Barbora
    Karaba, Marian
    Minarik, Gabriel
    Benca, Juraj
    Sedlackova, Tatiana
    Kalavska, Katarina
    Pindak, Daniel
    Mardiak, Jozef
    Celec, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [40] Differential gene expression in circulating tumor cells between primary and metastatic breast cancer patients
    Reinholz, M. M.
    Kitzmann, K. K.
    Hillman, D.
    Lingle, W. L.
    Hobday, T.
    Moreno, A.
    Vivek, R.
    Perez, E. A.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S213 - S214